Our study demonstrated that 63.61% of 294 lung cancer samples contained cytoplasmic Kaiso expression, which is a significant increase compared to normal bronchial epithelial cells (regarded as negative expression). This evidence concerns the gene ZBTB33 and lung carcinoma.